首页> 外文期刊>中国神经再生研究(英文版) >Effect of Tongxinluo on basic fibroblast growth factor mRNA after cerebral ischemia/reperfusion injury
【24h】

Effect of Tongxinluo on basic fibroblast growth factor mRNA after cerebral ischemia/reperfusion injury

机译:通心络对脑缺血/再灌注损伤后碱性成纤维细胞生长因子mRNA的影响

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND:Basic fibroblast growth factor(Bfgf)can cause proliferation and differentiation of plentiful cells which are derived from mesoblast and neural ectoblast.Previous researches suggested that Tongxinluo could promote differentiation from neural stem cells(NSCs)to neurons and astrocytes after cerebral ischemia/repefusion injury.OBJECTIVE:TO observe the effect of Tongxinluo on Bfgf Mrna of rats after cerebral ischemia/reperfusion injury and analyze its dosage-dependence.DESIGN:Randomized controlled study.SETTING:Department of Neurology,Nanfang Hospital of Southern Medical University.MATERIALS: The experiment was carried out in Neurological Department of Nanfang Hospital affiliated to Southern Medical University from May 2005 to March 2006.A total of 192 healthy Wistar rats, weighing (200±20)g,of SPF grade,of both gender by half,were provided by Experimental Animal Center of Nanfang Hospital Affiliated to Southern Medical University.Tongxinluo was consisted of renshen,wugong,quanxie.shuizhi chishao, bingpian, etc.and was provided by Shijiazhuang Yiing Pharmaceutical Co.,Ltd.(batchnumber:9906115).Main reagents:Agarose,DEPC-treated water,total RNA purification kit and one-step reverse transcription polymerase chain reaction(RT-PCR) kit were provided by Beijing Saibaisheng Gene Technique Co.,Ltd.METHODS:All rats were randomly divided into 4 groups,including high-dosage Tongxinluo group,low-dosage Tongxinluo group,model group and sham operation group with 48 in each group.Rats in the former three groups were observed at 3,5,7,14,21 and 30 days after ischemia/reperfusion.In addition,rats in sham operation group were selected at the relevant time points.Every 8 rats were selected from each group for once.①Right middle cerebral artery occlusion-reperfusion models were induced by Koizumi method and modified;moreover,neurological impairment was evaluated with Zealonga method.Except rats in sham operation group.rats in other three groups were involved in the final analysis.if scores of neurological impairment were higher than 2 at 6 hours after modeing.②Administration:Rats in high-dosage Tongxinluo group were perfused with 150 g/L 1 g/(kg·d) Tongxinluo suspension;rats in low-dosage Tongxinluo group were perfused with 75 g/L 0.5 g/(kg·d) Tongxinluo suspension;rats in sham operation group and control group were perfused with the same volume of distilled water.Rats in each group were administrated at the wakeful time after reperfusion immediately.③Preparation of brain tissue:Rats were anesthetized at 3,5,7,14,21 and 30 days after perfusion to obtain their brains,separete brain tissue on ischemic site,extract total RNA,perform RT-PCR and semi-quantitative analysis and defect expression of bF-GF mRNA at ischemic brain tissue.④Statistical analysis:Intensity at each time point was measured with analysis of variance and Ftest.MAIN OUTCOME MEASURES: Changes of bFGF mRNA during proliferation and differentiation of NSCs in ischemic brain tissue at each time point after cerebral ischemia/reperfusion injury.RESULTS:All 192 rats were involved in the final analysis.Expression of bFGF mRNA was hardly measured at focal side of rats in sham operation group.Otherwise.expression of bFGF mRNA was measured at various time points at ischemic side of rats in model group;moreover,the expression was the srongest on the 7th day,decreased on the 14th day and fallen down to the basic value on the 30th day.At 5,7,14.21 and 30 days after modeing,expressions of bFGF mRNA at focal side were 0.86±0.04,0.87±0.04:0.88±0.02,0.87±0.02;0.79±0.02, O.81±0.03;0.52±0.04, 0.54±0.04;0.46±O.03, 0.45±0.03 in high-dosage Tongxinluo group andlow-dosage Tongxinluo group,respectively,which were stronger than those in model group(0.62±0.06,0.63±O.05,0.52±0.06,0.43±0.06,0.19±0.04,P<0.05).Expression of bFGF mRNA at each time point was similar in high-dosage Tongxinluo group to that in low-dosage Tongxinluo group.In addition.expression of bFGF mRNA was the strongest at focal side in high-dosage Tongxinluo group and low-dosage Tongxinluo group on the 7th day after modeing;meanwhile,the expression was still stronger within 30 days after ischemia.CONCLUSION:①Tongxinluo can strengthen the expression of bFGF mRNA at ischemic side;meariwhile,the expression may last for 30 days.②This effect does not show as dosage-dependence.
机译:背景:基础成纤维细胞生长因子(Bfgf)可引起中胚层和神经外胚层来源的大量细胞的增殖和分化。以前的研究表明,通心络可促进脑缺血/再灌注后神经干细胞向神经元和星形胶质细胞的分化。目的:观察通心络对脑缺血/再灌注损伤大鼠Bfgf mRNA的影响,并分析其剂量依赖性。设计:随机对照研究。环境:南方医科大学附属南方医院神经内科。实验于2005年5月至2006年3月在南方医科大学附属南方医院神经内科进行。共提供192只健康的Wistar大鼠,体重(200±20)g,SPF级,性别均为一半。由南方医科大学附属南方医院实验动物中心提供。通心络由人参,武功,全西组成由石家庄亿宁药业有限公司提供(水芝赤s,冰片等)(批号:9906115)。主要试剂:琼脂糖,DEPC处理过的水,总RNA纯化试剂盒和一步反转录聚合酶链反应方法:将大鼠随机分为4组,分别为高剂量通心络组,低剂量通心络组,模型组和假手术组,每组48只。每组分别在缺血/再灌注后3、5、7、14、21和30天观察前三组的大鼠。此外,在相关时间点选择假手术组的大鼠。每组8只大鼠①采用小泉方法诱导右中脑动脉再灌注模型,并对其进行了改良;此外,采用Zealonga方法评价了神经功能障碍。假手术组除大鼠外,其余三组均参与了最终研究。分析②静坐后6小时神经功能缺损得分高于2分。②给药:高剂量通心络组大鼠灌胃150 g / L 1 g /(kg·d)通心络悬液;低剂量通心络组大鼠灌流组分别以75 g / L 0.5 g /(kg·d)通心络悬液灌流;假手术组和对照组大鼠灌入相同体积的蒸馏水。每组大鼠于再灌注后清醒时给药。 .③脑组织的制备:在灌注后3、5、7、14、21和30天麻醉大鼠,以获取其大脑,在缺血部位分离脑组织,提取总RNA,进行RT-PCR和半定量分析, ④统计分析:通过方差分析和Ftest分析每个时间点的强度。主要观察指标:缺血性脑组织NSCs增殖和分化过程中bFGF mRNA的变化。点结果:192只大鼠全部进入结果分析。假手术组大鼠局灶侧几乎未检测到bFGF mRNA的表达;否则,缺血后不同时间点均检测到bFGF mRNA的表达。模型组大鼠一侧;第7天表达最弱,第14天表达降低,第30天下降至基础值。在5、7、14.21和适度后第30天,表达降低。灶侧的bFGF mRNA为0.86±0.04,0.87±0.04:0.88±0.02,0.87±0.02; 0.79±0.02,O.81±0.03; 0.52±0.04,0.54±0.04; 0.46±O.03,0.45±0.03高剂量通心络组和低剂量通心络组分别优于模型组(0.62±0.06,0.63±O.05,0.52±0.06,0.43±0.06,0.19±0.04,P <0.05)。高剂量通心络组在每个时间点的bFGF mRNA的表达都与低剂量通心络组在每个时间点的相似。此外,bFGF mRNA的表达在hig的局灶侧最强静息后第7天给予h剂量通心络组和低剂量通心络组;同时在缺血后30天内表达仍较强。结论:①通心络可增强缺血侧bFGF mRNA的表达;同时,其表达可能增强持续30天。②这种作用并不表现为剂量依赖性。

著录项

  • 来源
    《中国神经再生研究(英文版)》 |2006年第6期|509-512|共4页
  • 作者单位

    Department of Neurology, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong Province, China;

    Department of Neurology, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong Province, China;

    Department of Neurology, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong Province, China;

    Department of Neurology, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong Province, China;

    Department of Neurology, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong Province, China;

    Department of Neurology, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong Province, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 基础医学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号